Pharmaceutical drug
Albiglutide Trade names Eperzan (Europe), Tanzeum (US) Other names GSK-716155 AHFS/Drugs.com tanzeum Routes of Subcutaneous (SC) ATC code Legal status Protein binding Probably none Metabolism Most likely proteolysis Elimination half-life 5 (4–7) days CAS Number PubChem SID DrugBank ChemSpider UNII KEGG Formula C 3232 H 5032 N 864 O 979 S 41 Molar mass 971 .34−1
Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2 diabetes.
As of 2017 it is unclear if it affects a person's risk of death.[2] GSK has announced that it intends to withdraw the drug from the worldwide market by July 2018 for economic reasons.
^ "Health Canada New Drug Authorizations: 2015 Highlights". Health Canada . 4 May 2016. Retrieved 7 April 2024 . ^ Liu J, Li L, Deng K, Xu C, Busse JW, Vandvik PO, et al. (June 2017). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ . 357 : j2499. doi:10.1136/bmj.j2499. PMC 5463186 . PMID 28596247.
Last Update: 2024-04-07T06:20:48Z
Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline...
Word Count : 1096
Last Update: 2024-05-27T18:14:10Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 5418
Last Update: 2023-12-20T06:49:28Z
rosuvastatin A10BJ01 Exenatide A10BJ02 Liraglutide A10BJ03 Lixisenatide A10BJ04 Albiglutide A10BJ05 Dulaglutide A10BJ06 Semaglutide A10BJ07 Beinaglutide A10BK01...
Word Count : 508
Last Update: 2024-03-22T03:35:15Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 262
Last Update: 2024-05-23T21:41:07Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 184
Last Update: 2024-04-07T06:23:31Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 1512
Last Update: 2024-05-27T22:29:41Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 507
Last Update: 2024-05-23T10:28:15Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 13792
Last Update: 2024-05-17T00:03:29Z
(Ozempic) (oral version is Rybelsus) Dulaglutide (Trulicity) - once weekly Albiglutide (Tanzeum) - once weekly These agents may also cause a decrease in gastric...
Word Count : 5099
Last Update: 2024-05-19T21:56:02Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 3481
Last Update: 2024-05-20T05:15:44Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 4939
Last Update: 2024-03-24T06:24:34Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 1575
Last Update: 2024-04-13T05:07:30Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 1890
Last Update: 2024-04-11T15:05:59Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 1622
Last Update: 2024-05-08T15:03:31Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 2518
Last Update: 2024-04-12T03:54:44Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 694
Last Update: 2023-12-20T19:33:15Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 888
Last Update: 2024-03-21T00:37:13Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 2379
Last Update: 2024-06-02T00:36:13Z
had collaborated on developing the lupus drug Belimumab (Benlysta), albiglutide for type 2 diabetes, and darapladib for atherosclerosis, and in September...
Word Count : 12184
Last Update: 2024-04-26T18:01:42Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 275
Last Update: 2024-04-13T05:09:46Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 2074
Last Update: 2024-03-31T22:13:00Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 894
Last Update: 2024-04-24T23:20:17Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 284
Last Update: 2024-04-27T22:39:33Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 2133
Last Update: 2024-06-04T05:58:49Z
K+ATP GLP-1 receptor agonists Albiglutide ‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
Word Count : 3502
Global Information